Abstract
Mucormycosis is a rare fungal infection that has been described mainly in oncologic and diabetic patients. We here report the cases of two leukaemic patients in whom pulmonary mucormycosis was diagnosed. Prompt diagnosis, therapy with amphotericin B and surgery when possible, are the cornerstones in the treatment of this fungal infection. Although infrequent, this infection must be suspected in oncohaematological patients with lung infiltrates.
MeSH terms
-
Adult
-
Aged
-
Amphotericin B / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cytarabine / administration & dosage
-
Fatal Outcome
-
Granulocyte Colony-Stimulating Factor / therapeutic use
-
Humans
-
Immunologic Factors / therapeutic use
-
Itraconazole / therapeutic use
-
Leukemia, Promyelocytic, Acute / complications*
-
Leukemia, Promyelocytic, Acute / drug therapy
-
Lung Diseases, Fungal / complications*
-
Lung Diseases, Fungal / diagnosis
-
Lung Diseases, Fungal / drug therapy
-
Male
-
Mercaptopurine / administration & dosage
-
Methotrexate / administration & dosage
-
Mitoxantrone / administration & dosage
-
Mucormycosis / complications*
-
Mucormycosis / diagnosis
-
Mucormycosis / drug therapy
-
Neutropenia / chemically induced
-
Neutropenia / complications
-
Neutropenia / therapy
-
Opportunistic Infections / complications*
-
Opportunistic Infections / diagnosis
-
Opportunistic Infections / drug therapy
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Substances
-
Immunologic Factors
-
Cytarabine
-
Granulocyte Colony-Stimulating Factor
-
Itraconazole
-
Amphotericin B
-
Mitoxantrone
-
Mercaptopurine
-
Methotrexate